In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
This video discusses IgA nephropathy (IgAN), a kidney disease where proteins from the immune system build up in the kidney filters, causing inflammation and potential damage. It details…
The CARE1 pragmatic clinical trial was designed to determine the optimal treatment combination for patients with metastatic kidney cancer, using a specific biomarker. The trial, funded by the…
Angela Belcher, PhD; Sangeeta Bhatia, MD, PhD; and Paula Hammond, PhD, from the Koch Institute at MIT, Cambridge, MA, present multi-dimensional approaches to early detection in ovarian cancer.…
Ken Berry, MD, a family physician, discusses polycystic kidney disease (PKD), the most common inherited kidney disease. PKD is characterized by enlarging cysts in the kidney that can…
Polycystic kidney disease (PKD) is a common cause of secondary hypertension, particularly in young people. PKD is a group of disorders, with the most relevant being autosomal dominant…
Mohamed Tinawi, MD, a nephrologist from Northwest Indiana, provides an update from Kidney Week 2023, discussing several significant studies and trials. Results from the DUPLEX trial, published in…
Michael Collins, MBChB, FRACP, PhD, a kidney transplant specialist at the Royal Adelaide Hospital, discusses his research on improving kidney transplant outcomes. He explains that during organ donation,…
Edward P.K. Kwakyi, BSc, and Rasheed A. Gbadegesin, MBBS, MD, FASN, discuss the role of apolipoprotein L1 (APOL1) in kidney diseases, particularly in people of African ancestry. APOL1…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses the treatment of large kidney tumors. Historically, most kidney cancers presented as large masses, but with advancements in…
Brad Leibovich, MD, a urologic oncologist at Mayo Clinic, explains that kidney cancer in its early stages often presents no signs or symptoms and there is no screening…
